22204-53-1 |
(S)-Naproxen |
Naprosyn |
(+)-Naproxen |
Naproxene |
Equiproxen |
(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
Aleve |
(S)-(+)-Naproxen |
d-Naproxen |
Ec-Naprosyn |
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid |
Laraflex |
Naprosyne |
Naproxeno |
Naproxenum |
Nycopren |
Calosen |
Naixan |
Reuxen |
Bonyl |
Axer |
(+)-(S)-Naproxen |
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
Novonaprox |
Acusprain |
Anexopen |
Apronax |
Artagen |
Arthrisil |
Artrixen |
Artroxen |
Atiflan |
Bipronyl |
Clinosyn |
Danaprox |
Flexipen |
Genoxen |
Lefaine |
Leniartil |
Nafasol |
Nalyxan |
Napflam |
Naposin |
Naprius |
Veradol |
Congex |
Daprox |
Fuxen |
Napmel |
Napren |
Naxen |
Naxyn |
Xenar |
Dysmenalgit N |
Apo-Naproxen |
naproxen(+) |
Floginax |
Napratec |
Naprontag |
Naxopren |
Pronaxen |
Rheumaflex |
Saritilron |
Sinartrin |
Soproxen |
Anaprox |
Flexen |
Headlon |
Napxen |
Narocin |
Noflam |
Patxen |
Prafena |
Priaxen |
Rahsen |
Sinton |
Sutolin |
Sutony |
Tohexen |
Traumox |
Velsay |
Vinsen |
Narma |
Naxid |
Roxen |
Anax |
Flanax Forte |
Naprosyn LLE |
Napren E |
Proxen LE |
Naxen F |
Proxen LLE |
U-Ritis |
RS-3540 |
(S)-2-(6-Methoxy-2-naphthyl)propionic acid |
(+)-2-(6-Methoxy-2-naphthyl)propionic acid |
Naprosyn LLE Forte |
Naproxi 250 |
Naproxi 500 |
(+)-2-(Methoxy-2-naphthyl)-propionic acid |
Naxyn 250 |
Naxyn 500 |
Xenar-CR |
(S)-2-(6-Methoxy-2-naphthyl)propanoic acid |
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
d-2-(6-Methoxy-2-naphthyl)propionic acid |
(+)-2-(Methoxy-2-naphthyl)-propionsaeure |
CCRIS 5265 |
CHEBI:7476 |
Diocodal |
Naprolag |
Naprosine |
Naprosy |
Prexan |
CG 3117 |
Apo-Napro-NA |
(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
HSDB 3369 |
Naproxene [INN-French] |
Naproxenum [INN-Latin] |
Naproxeno [INN-Spanish] |
EINECS 244-838-7 |
UNII-57Y76R9ATQ |
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
Dysmenalgit |
NSC-750183 |
NSC-757239 |
Proxen |
RS 3540 |
57Y76R9ATQ |
DTXSID4040686 |
PN400 COMPONENT NAPROXEN |
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure |
CHEMBL154 |
(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)- |
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- |
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)- |
Duk |
VIMOVO COMPONENT NAPROXEN |
DTXCID2020686 |
Methoxypropiocin |
(2S)-2-(6-methoxy-2-naphthyl)propanoic acid |
EC 244-838-7 |
NAPROXEN COMPONENT OF VIMOVO |
Apranax |
Naprium |
Naprux |
Naproxen [USAN:USP:INN:BAN:JAN] |
NSC 750183 |
NSC 757239 |
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)- |
Naproxene (INN-French) |
Naproxenum (INN-Latin) |
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)- |
CAS-22204-53-1 |
Naproxeno (INN-Spanish) |
NAPROXEN (MART.) |
NAPROXEN [MART.] |
NAPROXEN (USP-RS) |
NAPROXEN [USP-RS] |
(S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid |
NAPROXEN (EP MONOGRAPH) |
NAPROXEN [EP MONOGRAPH] |
(alphas)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid |
(S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid |
NAPROXEN (USP MONOGRAPH) |
NAPROXEN [USP MONOGRAPH] |
Equiproxen (Veterinary) |
Naproxen (USAN:USP:INN:BAN:JAN) |
Panoxen |
Proxine |
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetate |
Mnpa |
Naproxen oral |
SR-01000075977 |
DL Naproxen |
Equiproxen Granules |
Naprosyn (TN) |
Naproxen,(S) |
NPS |
Prestwick_349 |
(+)-2-(Methoxy-2-naphthyl)-propionsaeure [German] |
MFCD00010500 |
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German] |
Naproxendelayed release |
EC-NAPROXEN |
S-NAPROXEN |
6-methoxy-alpha-methyl-2-naphthaleneacetic acid |
Spectrum_000977 |
4or0 |
4po0 |
NAPROXEN [HSDB] |
NAPROXEN [INCI] |
NAPROXEN [USAN] |
(S)-(+)-Naproxene |
NAPROXEN [INN] |
NAPROXEN [JAN] |
Naproxen Delayed Release |
Naproxen Oral Suspension |
NAPROXEN [MI] |
NAPROXEN [VANDF] |
Prestwick0_000791 |
Prestwick1_000791 |
Prestwick2_000791 |
Spectrum2_001043 |
Spectrum3_000514 |
Spectrum4_000069 |
Spectrum5_001327 |
(+)NAPROXEN |
Equiproxen 10% Solution |
Naproxen2-(6-Methoxy-naphthalen-2-yl)-propionic acid |
Epitope ID:139974 |
NAPROXEN [WHO-DD] |
UPCMLD-DP001 |
2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen) |
SCHEMBL3046 |
Lopac0_000792 |
BSPBio_002067 |
KBioGR_000597 |
KBioSS_001457 |
BIDD:GT0062 |
DivK1c_000242 |
NAPROXEN [GREEN BOOK] |
SPECTRUM1500425 |
Naproxen (JP17/USP/INN) |
Naproxen, 1mg/ml in Methanol |
SPBio_000966 |
SPBio_002861 |
NAPROXEN [ORANGE BOOK] |
GTPL5230 |
UPCMLD-DP001:001 |
CMWTZPSULFXXJA-VIFPVBQESA- |
HMS500M04 |
KBio1_000242 |
KBio2_001457 |
KBio2_004025 |
KBio2_006593 |
KBio3_001567 |
G02CC02 |
M01AE02 |
M02AA12 |
Naproxen 1.0 mg/ml in Methanol |
NINDS_000242 |
HMS1920P13 |
HMS2089N21 |
HMS2091H12 |
HMS3649M13 |
HMS3886C15 |
Pharmakon1600-01500425 |
Tox21_301953 |
BDBM50339185 |
CCG-40130 |
NSC750183 |
NSC757239 |
AKOS005267223 |
AC-1363 |
DB00788 |
ME-0100 |
SDCCGSBI-0050769.P005 |
IDI1_000242 |
Naproxen 100 microg/mL in Acetonitrile |
NCGC00016759-01 |
NCGC00016759-02 |
NCGC00016759-03 |
NCGC00016759-38 |
NCGC00021127-01 |
NCGC00161591-01 |
NCGC00255562-01 |
HY-15030 |
(+)-2-(Methoxy-2-naphthyl)-propionsaure |
Naproxen, meets USP testing specifications |
SBI-0050769.P004 |
Sallus Pain Relief Collection With Naproxen |
AM20060551 |
M1021 |
S5177 |
Naproxen, VETRANAL(TM), analytical standard |
(2S)-2-(6-Methoxynaphth-2-yl)propanoic acid |
(S)-2-(6-methoxy-2-naphthyl)-propionic acid |
(S)-2-(6-methoxynaphthalen-2-yl)propanoicacid |
C01517 |
d-2-(6'-methoxy-2'-naphthyl)-propionic acid |
D00118 |
EN300-139795 |
O10203 |
(2S)-2-(6-methoxy(2-naphthyl))propanoic acid |
AB00052049-04 |
AB00052049_05 |
()-2-(METHOXY-2-NAPHTHYL)-PROPIONIC ACID |
()-2-(METHOXY-2-NAPHTHYL)-PROPIONSAEURE |
(+)(S)2-(6-methoxy-2-naphthyl)-propionic acid |
2-(6-Methoxy-2-naphthyl)propanoic acid , (+)- |
SR-01000003110 |
Q-201447 |
Q1215575 |
SR-01000003110-5 |
SR-01000075977-3 |
SR-01000075977-4 |
(+)-6-Methoxy-.alpha.-methyl-2-napthaleneacetic acid |
BRD-K59197931-001-02-9 |
BRD-K59197931-001-03-7 |
BRD-K59197931-236-09-6 |
SR-01000075977-10 |
(+)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid |
(S)-(+)-2-(6-methoxy-naphthalen-2-yl)-propionic acid |
(S)-6-Methoxy-.alpha.-methyl-2-naphthalene acetic acid |
2-naphthaleneacetic acid, 6-methoxy-alpha-methyl, (S)- |
2-naphthleneacetic acid, 6-methoxy-alpha-methyl-, (+)- |
Naproxen, British Pharmacopoeia (BP) Reference Standard |
Naproxen, European Pharmacopoeia (EP) Reference Standard |
PROPIONIC ACID, 2-(METHOXY-2-NAPHTHYL)-, ()- |
Z1695772815 |
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, 98% |
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (+)- |
Naproxen, United States Pharmacopeia (USP) Reference Standard |
(+)-(S)-6-METHOXY-.ALPHA.-METHYL-2-NAPHTHALENEACETIC ACID |
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material |
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic Acid;(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid |
131991-52-1 |
d-Naproxen; (2S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid; (S)-6-Methoxy-?-methyl-2-naphthaleneacetic Acid; d-2-(6-Methoxy-2-naphthyl)propionic Acid |
InChI=1/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1 |
There are more than 10 synonyms. If you wish to see them all click here.
|